Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry, 4023 [2023-01133]

Download as PDF Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices following basic class(es) of controlled substances: Controlled substance Marihuana ..................... Drug code 7360 Schedule [FR Doc. 2023–01207 Filed 1–20–23; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1128] Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry Drug code Controlled substance I Matthew Strait, Deputy Assistant Administrator. khammond on DSKJM1Z7X2PROD with NOTICES 200, Eugene, Oregon 97402–4109, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Amphetamine ......................... Methylphenidate ..................... Codeine .................................. Oxycodone ............................. Hydromorphone ..................... Hydrocodone .......................... Meperidine ............................. Meperidine intermediate-A ..... Meperidine intermediate-B ..... Meperidine intermediate-C .... Methadone ............................. Methadone intermediate ........ Morphine ................................ Thebaine ................................ Oxymorphone ........................ Noroxymorphone ................... Fentanyl ................................. Schedule 1100 1724 9050 9143 9150 9193 9230 9232 9233 9234 9250 9254 9300 9333 9652 9668 9801 II II II II II II II II II II II II II II II II II The company plans to bulk manufacture small quantities of the AGENCY: Drug Enforcement listed controlled substances for internal Administration, Justice. use or for sale as analytical reference ACTION: Notice of application. standard materials to its customers. No SUMMARY: Organic Consultants LLC DBA other activities for these drug codes are authorized for this registration. Cascade Chemistry has applied to be registered as a bulk manufacturer of Matthew Strait, basic class(es) of controlled Deputy Assistant Administrator. substance(s). Refer to SUPPLEMENTARY [FR Doc. 2023–01133 Filed 1–20–23; 8:45 am] INFORMATION listed below for further BILLING CODE P drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and DEPARTMENT OF LABOR applicants therefore, may submit electronic comments on or objections to Employee Benefits Security the issuance of the proposed registration Administration on or before March 24, 2023. Such persons may also file a written request [Prohibited Transaction Exemption 2023– 02; Exemption Application No. D–12067] for a hearing on the application on or before March 24, 2023. Exemption for Certain Prohibited ADDRESSES: The Drug Enforcement Transaction Restrictions Involving Administration requires that all Citigroup, Inc. (Citigroup or the comments be submitted electronically through the Federal eRulemaking Portal, Applicant), Located in New York, New York which provides the ability to type short comments directly into the comment AGENCY: Employee Benefits Security field on the web page or attach a file for Administration, Labor. lengthier comments. Please go to ACTION: Notice of exemption. https://www.regulations.gov and follow the online instructions at that site for SUMMARY: This document contains a submitting comments. Upon submission notice of an exemption issued by the of your comment, you will receive a Department of Labor (the Department) Comment Tracking Number. Please be extending the exemptive relief provided aware that submitted comments are not by PTE 2017–05 for an additional four instantaneously available for public (4) years. This exemption provides that view on https://www.regulations.gov. If certain entities with specified you have received a Comment Tracking relationships to Citigroup (hereinafter, Number, your comment has been the Citigroup Affiliated QPAMs and the successfully submitted and there is no Citigroup Related QPAMs, as defined in need to resubmit the same comment. Sections I(b) and I(c), respectively) will not be precluded from relying on the SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this exemptive relief provided by Prohibited Transaction Class Exemption 84–14 is notice that on November 9, 2022, (PTE 84–14 or the QPAM Exemption), Organic Consultants LLC DBA Cascade notwithstanding the Conviction Chemistry, 90 North Polk Street, Suite VerDate Sep<11>2014 16:44 Jan 20, 2023 Jkt 259001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 4023 (defined in Section I(a)), during the Exemption Period (as defined in Section I(d)). DATES: This exemption will be in effect from January 10, 2023, through January 9, 2027. FOR FURTHER INFORMATION CONTACT: Anna Mpras Vaughan of the Department at (202) 693–8565. (This is not a toll-free number.) SUPPLEMENTARY INFORMATION: The Applicant requested an individual exemption pursuant to ERISA Section 408(a) in accordance with the procedures set forth in 29 CFR part 2570, subpart B (76 FR 66637, 66644, October 27, 2011). On November 16, 2022, the Department published a notice of proposed exemption (the Proposed Exemption) in the Federal Register that would permit Citigroup Affiliated QPAMs and the Citigroup Related QPAMs to continue relying on the exemptive relief provided by the QPAM Exemption notwithstanding the Conviction provided certain conditions are met.1 The Conviction: On January 10, 2017, Citicorp, a Delaware corporation that is a financial services holding company and the direct parent company of Citigroup, pled guilty to one count of an antitrust violation of the Sherman Antitrust Act (15 U.S.C. 1) arising from an investigation conducted by the U.S. Department of Justice (DOJ) of certain conduct and practices of Citigroup and other financial services firms in the foreign exchange (FX) spot market.2 As set forth in the Plea Agreement, from at least December 2007 until at least January 2013, Citicorp, through one London-based Euro/U.S. dollar (EUR/ USD) trader employed by Citibank and other traders at unrelated financial services firms acting as dealers in the FX spot market entered into and engaged in a conspiracy to fix, stabilize, maintain, increase or decrease the price of, and rig bids and offers for, the EUR/ USD currency pair exchanged in the FX spot market by agreeing to eliminate competition in the purchase and sale of the EUR/USD currency pair in the United States and elsewhere (the Criminal Misconduct). The Criminal Misconduct included almost daily conversations, some of which were in code, in an exclusive electronic chat room used by certain EUR/USD traders, including the EUR/USD trader employed by Citibank. The Criminal 1 87 FR 68728, November 16, 2022. plea agreement with the DOJ (the Plea Agreement), was approved by the U.S. District Court for the District of Connecticut (the District Court) on January 10, 2017 (Case Number 3:15–cr– 78–SRU). 2 Citicorp’s E:\FR\FM\23JAN1.SGM 23JAN1

Agencies

[Federal Register Volume 88, Number 14 (Monday, January 23, 2023)]
[Notices]
[Page 4023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01133]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1128]


Bulk Manufacturer of Controlled Substances Application: Organic 
Consultants LLC DBA Cascade Chemistry

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Organic Consultants LLC DBA Cascade Chemistry has applied to 
be registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
March 24, 2023. Such persons may also file a written request for a 
hearing on the application on or before March 24, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on November 9, 2022, Organic Consultants LLC DBA Cascade 
Chemistry, 90 North Polk Street, Suite 200, Eugene, Oregon 97402-4109, 
applied to be registered as a bulk manufacturer of the following basic 
class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Amphetamine............................     1100  II
Methylphenidate........................     1724  II
Codeine................................     9050  II
Oxycodone..............................     9143  II
Hydromorphone..........................     9150  II
Hydrocodone............................     9193  II
Meperidine.............................     9230  II
Meperidine intermediate-A..............     9232  II
Meperidine intermediate-B..............     9233  II
Meperidine intermediate-C..............     9234  II
Methadone..............................     9250  II
Methadone intermediate.................     9254  II
Morphine...............................     9300  II
Thebaine...............................     9333  II
Oxymorphone............................     9652  II
Noroxymorphone.........................     9668  II
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture small quantities of the 
listed controlled substances for internal use or for sale as analytical 
reference standard materials to its customers. No other activities for 
these drug codes are authorized for this registration.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-01133 Filed 1-20-23; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.